相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant IDH1 is required for IDH1 mutated tumor cell growth
Genglin Jin et al.
Oncotarget (2015)
Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia
Rimma Berenstein et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma
Stefan Pusch et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
Aurelie Catteau et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Molecular subtypes of glioma identified by genome-wide methylation profiling
Nanne K. Kloosterhof et al.
GENES CHROMOSOMES & CANCER (2013)
The good, the bad and the ugly: Epigenetic mechanisms' in glioblastoma
Helena Caren et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
Gavin P. Dunn et al.
NEUROSURGICAL FOCUS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
J. A. Carrillo et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
Whitney B. Pope et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Detection of IDH1 mutation in the plasma of patients with glioma
Blandine Boisselier et al.
NEUROLOGY (2012)
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
Ovidiu C. Andronesi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG
Beth Pietrak et al.
BIOCHEMISTRY (2011)
The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
Andreas von Deimling et al.
BRAIN PATHOLOGY (2011)
Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
Shingo Takano et al.
BRAIN TUMOR PATHOLOGY (2011)
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Christian Hartmann et al.
CLINICAL CANCER RESEARCH (2011)
A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma From Astrocytosis: Chromosome 7 Gain With Mutant Isocitrate Dehydrogenase 1 and p53
Sandra Camelo-Piragua et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
M. Fernanda Amary et al.
NATURE GENETICS (2011)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Philippe Metellus et al.
ACTA NEUROPATHOLOGICA (2010)
Molecular Classification of Low-Grade Diffuse Gliomas
Young Ho Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value
Saman Abbas et al.
BLOOD (2010)
PCR- and Restriction Endonuclease-Based Detection of IDH1 Mutations
Jochen Meyer et al.
BRAIN PATHOLOGY (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J. van den Bent et al.
CLINICAL CANCER RESEARCH (2010)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
COLD PCR HRM: A Highly Sensitive Detection Method for IDH1 Mutations
Blandine Boisselier et al.
HUMAN MUTATION (2010)
Segregation of Non-p.R132H Mutations in IDH1 in Distinct Molecular Subtypes of Glioma
Lonneke A. M. Gravendeel et al.
HUMAN MUTATION (2010)
Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas
Silke Goetze et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples
Prashanth Setty et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
O. Kosmider et al.
LEUKEMIA (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
M. Labussiere et al.
NEUROLOGY (2010)
A microarray-based DNA methylation study of glioblastoma multiforme
Ramon Martinez et al.
EPIGENETICS (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
H. J. Dubbink et al.
NEUROLOGY (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
Laura E. MacConaill et al.
PLOS ONE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Copy number alterations of the polycomb gene BMI1 in gliomas
Valtteri Hayry et al.
ACTA NEUROPATHOLOGICA (2008)
Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue:: class II and IV are hypoexpressed in glioblastomas
Agda Kb Lucio-Eterovic et al.
BMC CANCER (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Reciprocal regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme
Hong Zhou et al.
CLINICAL CANCER RESEARCH (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
Michael Weber et al.
NATURE GENETICS (2007)
Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation
Benoit Cadieux et al.
CANCER RESEARCH (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epigenetic silencing of the protocadherin family member PCDH-γ-A11 in astrocytomas
A Waha et al.
NEOPLASIA (2005)
分享论文
